PDF herunterladen
Am J Perinatol 2023; 40(09): 996-1001
DOI: 10.1055/s-0043-1761639
PAS Series Article
Review Article

The Need for Presurgical Evaluation for Placenta Accreta Spectrum

Brett D. Einerson
1   University of Utah Health, Salt Lake City, Utah
,
Alireza A. Shamshirsaz
Maternal Fetal Care Center, Boston Children's Hospital, Boston, Massachusetts
Brigham and Women's Hospital Harvard Medical School, Boston, Massachusetts
,
Megan L. Stephenson
Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Kaiser Permanente, Santa Clara, California
,
Meena Khandelwal
Department of Obstetrics and Gynecology, Cooper Medical School of Rowan University, Camden, New Jersey
,
Roxane Holt
Department of Obstetrics and Gynecology, University of Chicago, Chicago, Illinois
,
Christina M. Duzyj
Massachusetts General Hospital, Department of Obstetrics and Gynecology, Boston, Massachusetts
Harvard Medical School, Department of Obstetrics, Gynecology and Reproductive Biology, Boston, Massachusetts
,
Vineet K. Shrivastava
MemorialCare Miller Children's & Women's Hospital, Maternal-Fetal Medicine, Department of Obstetrics & Gynecology, Long Beach, California
› Institutsangaben
› Weitere Informationen
    Lizenzen und Reprints

Abstract

Staging or grading of placenta accreta spectrum has historically relied on histopathologic evaluation of placental and uterine specimens. This approach has limited utility, since it is retrospective in nature and does not allow for presurgical planning. Here, we argue for a paradigm shift to use of clinical and imaging characteristics to define the presurgical stage. We summarize past attempts at staging, and define a new data-driven approach to determining the stage prior to delivery. Use of this model may help hospitals direct patients to the most appropriate level of care for workup and management of placenta accreta spectrum.

Key Points

  • Staging systems that rely on histopathologic grade (accreta, increta, percreta) are unhelpful in antenatal planning for placenta accreta spectrum.

  • Past attempts at pre-delivery (pre-surgical) staging have failed to account for key factors that contribute to risk and morbidity.

  • We developed a data-driven model that could be easily incorporated as a decision aid into clinical practice to help clinicians decide an individual patient's risk for placenta accreta spectrum.

Keywords

prenatal ultrasound - risk assessment - hemorrhage - levels of maternal care - hysterectomy


Publikationsverlauf

Artikel online veröffentlicht:
19. Juni 2023

© 2023. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Forster DS. A case of placenta accreta. Can Med Assoc J 1927; 17 (02) 204-207
    PubMedGoogle Scholar
  • 2 Odicino F, Pecorelli S, Zigliani L, Creasman WT. History of the FIGO cancer staging system. Int J Gynaecol Obstet 2008; 101 (02) 205-210
    CrossrefPubMedGoogle Scholar
  • 3 Clark HR, Ng TW, Khan A. et al. Placenta accreta spectrum: correlation of MRI parameters with pathologic and surgical outcomes of high-risk pregnancies. AJR Am J Roentgenol 2020; 214 (06) 1417-1423
    CrossrefPubMedGoogle Scholar
  • 4 Cali G, Timor-Tritsch I, Forlani F. et al. Integration of first-trimester assessment in the ultrasound staging of placenta accreta spectrum disorders. Ultrasound Obstet Gynecol 2019
    PubMedGoogle Scholar
  • 5 Cali G, Forlani F, Lees C. et al. Prenatal ultrasound staging system for placenta accreta spectrum disorders. Ultrasound Obstet Gynecol 2019; 53 (06) 752-760
    CrossrefPubMedGoogle Scholar
  • 6 Knight JC, Lehnert S, Shanks AL. et al. A comprehensive severity score for the morbidly adherent placenta: combining ultrasound and magnetic resonance imaging. Pediatr Radiol 2018; 48 (13) 1945-1954
    CrossrefPubMedGoogle Scholar
  • 7 Maymon R, Melcer Y, Pekar-Zlotin M, Shaked O, Cuckle H, Tovbin J. Bedside risk estimation of morbidly adherent placenta using simple calculator. Arch Gynecol Obstet 2018; 297 (03) 631-635
    CrossrefPubMedGoogle Scholar
  • 8 Tovbin J, Melcer Y, Shor S. et al. Prediction of morbidly adherent placenta using a scoring system. Ultrasound Obstet Gynecol 2016; 48 (04) 504-510
    CrossrefPubMedGoogle Scholar
  • 9 Ueno Y, Maeda T, Tanaka U. et al. Evaluation of interobserver variability and diagnostic performance of developed MRI-based radiological scoring system for invasive placenta previa. J Magn Reson Imaging 2016; 44 (03) 573-583
    CrossrefPubMedGoogle Scholar
  • 10 Rac MW, Dashe JS, Wells CE, Moschos E, McIntire DD, Twickler DM. Ultrasound predictors of placental invasion: the Placenta Accreta Index. Am J Obstet Gynecol 2015; 212 (03) 343.e1-343.e7
    CrossrefPubMedGoogle Scholar
  • 11 Weiniger CF, Einav S, Deutsch L, Ginosar Y, Ezra Y, Eid L. Outcomes of prospectively-collected consecutive cases of antenatal-suspected placenta accreta. Int J Obstet Anesth 2013; 22 (04) 273-279
    CrossrefPubMedGoogle Scholar
  • 12 Palacios Jaraquemada JM, Bruno CH. Magnetic resonance imaging in 300 cases of placenta accreta: surgical correlation of new findings. Acta Obstet Gynecol Scand 2005; 84 (08) 716-724
    CrossrefPubMedGoogle Scholar
  • 13 Bourgioti C, Zafeiropoulou K, Fotopoulos S. et al. MRI features predictive of invasive placenta with extrauterine spread in high-risk gravid patients: a prospective evaluation. AJR Am J Roentgenol 2018; 211 (03) 701-711
    CrossrefPubMedGoogle Scholar
  • 14 Calì G, Giambanco L, Puccio G, Forlani F. Morbidly adherent placenta: evaluation of ultrasound diagnostic criteria and differentiation of placenta accreta from percreta. Ultrasound Obstet Gynecol 2013; 41 (04) 406-412
    CrossrefPubMedGoogle Scholar
  • 15 Creanga AA, Bateman BT, Butwick AJ. et al. Morbidity associated with cesarean delivery in the United States: is placenta accreta an increasingly important contributor?. Am J Obstet Gynecol 2015; 213 (03) 384.e1-384.e11
    CrossrefPubMedGoogle Scholar
  • 16 Clark SL, Koonings PP, Phelan JP. Placenta previa/accreta and prior cesarean section. Obstet Gynecol 1985; 66 (01) 89-92
    PubMedGoogle Scholar
  • 17 Miller DA, Chollet JA, Goodwin TM. Clinical risk factors for placenta previa-placenta accreta. Am J Obstet Gynecol 1997; 177 (01) 210-214
    CrossrefPubMedGoogle Scholar
  • 18 Silver RM, Landon MB, Rouse DJ. et al; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol 2006; 107 (06) 1226-1232
    CrossrefPubMedGoogle Scholar
  • 19 Marshall NE, Fu R, Guise JM. Impact of multiple cesarean deliveries on maternal morbidity: a systematic review. Am J Obstet Gynecol 2011; 205 (03) 262.e1-262.e8
    CrossrefPubMedGoogle Scholar
  • 20 Bailit JL, Grobman WA, Rice MM. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. Morbidly adherent placenta treatments and outcomes. Obstet Gynecol 2015; 125 (03) 683-689
    CrossrefPubMedGoogle Scholar
  • 21 Thurn L, Lindqvist PG, Jakobsson M. et al. Abnormally invasive placenta-prevalence, risk factors and antenatal suspicion: results from a large population-based pregnancy cohort study in the Nordic countries. BJOG 2016; 123 (08) 1348-1355
    CrossrefPubMedGoogle Scholar
  • 22 Carusi DA, Fox KA, Lyell DJ, Perlman NC, Aalipour S, Einerson BD, Belfort MA, Silver RM, Shamshirsaz AA. Placenta Accreta Spectrum Without Placenta Previa. Obstet Gynecol 2020; Sep; 136 (03) 458-465
    CrossrefPubMedGoogle Scholar
  • 23 Fitzpatrick KE, Sellers S, Spark P, Kurinczuk JJ, Brocklehurst P, Knight M. Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study. PLoS One 2012; 7 (12) e52893
    CrossrefPubMedGoogle Scholar
  • 24 Hung TH, Shau WY, Hsieh CC, Chiu TH, Hsu JJ, Hsieh TT. Risk factors for placenta accreta. Obstet Gynecol 1999; 93 (04) 545-550
    PubMedGoogle Scholar
  • 25 Farquhar CM, Li Z, Lensen S. et al. Incidence, risk factors and perinatal outcomes for placenta accreta in Australia and New Zealand: a case-control study. BMJ Open 2017; 7 (10) e017713
    CrossrefPubMedGoogle Scholar
  • 26 Bowman ZS, Eller AG, Bardsley TR, Greene T, Varner MW, Silver RM. Risk factors for placenta accreta: a large prospective cohort. Am J Perinatol 2014; 31 (09) 799-804
    PubMedGoogle Scholar
  • 27 Baldwin HJ, Patterson JA, Nippita TA. et al. Antecedents of abnormally invasive placenta in primiparous women: risk associated with gynecologic procedures. Obstet Gynecol 2018; 131 (02) 227-233
    CrossrefPubMedGoogle Scholar
  • 28 Jauniaux E, Collins S, Burton GJ. Placenta accreta spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol 2018; 218 (01) 75-87
    CrossrefPubMedGoogle Scholar
  • 29 Salmanian B, Fox KA, Arian SE. et al. In vitro fertilization as an independent risk factor for placenta accreta spectrum. Am J Obstet Gynecol 2020; 223 (04) 568.e1-568.e5
    CrossrefPubMedGoogle Scholar
  • 30 Modest AM, Toth TL, Johnson KM, Shainker SA. Placenta accreta spectrum: in vitro fertilization and non-in vitro fertilization and placenta accreta spectrum in a Massachusetts cohort. Am J Perinatol 2021; 38 (14) 1533-1539
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 31 Bauer AM, Hackney DN, El-Nashar S, Sheyn D. Pregnancy outcomes after endometrial ablation in a multi-institutional cohort. Am J Perinatol 2018; 35 (10) 931-935
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 32 Kohn JR, Shamshirsaz AA, Popek E, Guan X, Belfort MA, Fox KA. Pregnancy after endometrial ablation: a systematic review. BJOG 2018; 125 (01) 43-53
    CrossrefPubMedGoogle Scholar
  • 33 Sentilhes L, Ambroselli C, Kayem G. et al. Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol 2010; 115 (03) 526-534
    CrossrefPubMedGoogle Scholar
  • 34 Miller ES, Linn RL, Ernst LM. Does the presence of placental basal plate myometrial fibres increase the risk of subsequent morbidly adherent placenta: a case-control study. BJOG 2016; 123 (13) 2140-2145
    CrossrefPubMedGoogle Scholar
  • 35 Zelop C, Nadel A, Frigoletto Jr FD, Pauker S, MacMillan M, Benacerraf BR. Placenta accreta/percreta/increta: a cause of elevated maternal serum alpha-fetoprotein. Obstet Gynecol 1992; 80 (04) 693-694
    PubMedGoogle Scholar
  • 36 Kupferminc MJ, Tamura RK, Wigton TR, Glassenberg R, Socol ML. Placenta accreta is associated with elevated maternal serum alpha-fetoprotein. Obstet Gynecol 1993; 82 (02) 266-269
    PubMedGoogle Scholar
  • 37 Lyell DJ, Faucett AM, Baer RJ. et al. Maternal serum markers, characteristics and morbidly adherent placenta in women with previa. J Perinatol 2015; 35 (08) 570-574
    CrossrefPubMedGoogle Scholar
  • 38 Einerson BD, Straubhar A, Soisson S. et al. Hyperglycosylated hCG and placenta accreta spectrum. Am J Perinatol 2019; 36 (01) 22-26
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 39 Shainker SA, Silver RM, Modest AM. et al. Placenta accreta spectrum: biomarker discovery using plasma proteomics. Am J Obstet Gynecol 2020; 223 (03) 433.e1-433.e14
    CrossrefPubMedGoogle Scholar
  • 40 Twickler DM, Lucas MJ, Balis AB. et al. Color flow mapping for myometrial invasion in women with a prior cesarean delivery. J Matern Fetal Med 2000; 9 (06) 330-335
    CrossrefPubMedGoogle Scholar
  • 41 Shih JC, Palacios Jaraquemada JM, Su YN. et al. Role of three-dimensional power Doppler in the antenatal diagnosis of placenta accreta: comparison with gray-scale and color Doppler techniques. Ultrasound Obstet Gynecol 2009; 33 (02) 193-203
    CrossrefPubMedGoogle Scholar
  • 42 Wong HS, Cheung YK, Zuccollo J, Tait J, Pringle KC. Evaluation of sonographic diagnostic criteria for placenta accreta. J Clin Ultrasound 2008; 36 (09) 551-559
    CrossrefPubMedGoogle Scholar
  • 43 D'Antonio F, Iacovella C, Bhide A. Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2013; 42 (05) 509-517
    CrossrefPubMedGoogle Scholar
  • 44 D'Antonio F, Iacovella C, Palacios-Jaraquemada J, Bruno CH, Manzoli L, Bhide A. Prenatal identification of invasive placentation using magnetic resonance imaging: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2014; 44 (01) 8-16
    CrossrefPubMedGoogle Scholar